Biotech · Private company · Ann Arbor, MI, US
Esperion Therapeutics, Inc.
SEC CIK 0001434868
Track this companyFree. Adds Esperion Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline23
- bempedoic acidPhase 3 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic AcidPhase 3 · HyperlipidemiasClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic Acid + Ezetimibe Fixed-Dose CombinationPhase 3 · HyperlipidemiasClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic acid 180 mg tabletPhase 3 · Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- ETC-1002Phase 3 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- EzetimibePhase 3 · HyperlipidemiasClinicalTrials.gov · fetched Nov 12, 2026
- EzetimibePhase 3 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- AtorvastatinPhase 2 · HyperlipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- AtorvastatinPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Atorvastatin 20mgPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic acid + Ezetimibe FDC Oral TabletPhase 2 · DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic acid 180mgPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- ETC-1002Phase 2 · HyperlipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- ETC-1002Phase 2 · DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
- evolocumabPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Ezetimibe 10 mg Oral TabletPhase 2 · DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Ezetimibe 10mgPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Statin TherapyPhase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- ETC-1002Phase 1 · Safety Evaluation of Escalating DosesClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic AcidPregnancyClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic Acid / EzetimibePregnancyClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic Acid 180 MG Oral TabletHealthy Lactating WomenClinicalTrials.gov · fetched Nov 12, 2026
- Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral TabletHealthy Lactating WomenClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating WomenPHASE4 · COMPLETED · started Aug 4, 2023ClinicalTrials.gov NCT06021951 · fetched Nov 12, 2026
- Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering TherapyNA · RECRUITING · started Mar 1, 2023ClinicalTrials.gov NCT06300450 · fetched Nov 12, 2026
- A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)PHASE2 · COMPLETED · started Jan 12, 2023ClinicalTrials.gov NCT05694260 · fetched Nov 12, 2026
- Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome StudyPHASE4 · UNKNOWN · started Mar 1, 2022ClinicalTrials.gov NCT05263778 · fetched Nov 12, 2026
- Bempedoic Acid Pregnancy Surveillance ProgramRECRUITING · started Sep 1, 2021ClinicalTrials.gov NCT05103254 · fetched Nov 12, 2026
- Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-CPHASE2 · COMPLETED · started May 9, 2018ClinicalTrials.gov NCT03531905 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin TherapyPHASE3 · COMPLETED · started Oct 23, 2017ClinicalTrials.gov NCT03337308 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor TherapyPHASE2 · COMPLETED · started Apr 7, 2017ClinicalTrials.gov NCT03193047 · fetched Nov 12, 2026
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)PHASE3 · COMPLETED · started Feb 3, 2017ClinicalTrials.gov NCT03067441 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CPHASE2 · COMPLETED · started Jan 19, 2017ClinicalTrials.gov NCT03051100 · fetched Nov 12, 2026
- Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or PlaceboPHASE3 · COMPLETED · started Dec 22, 2016ClinicalTrials.gov NCT02993406 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)PHASE3 · COMPLETED · started Nov 29, 2016ClinicalTrials.gov NCT03001076 · fetched Nov 12, 2026
- Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskPHASE3 · COMPLETED · started Nov 18, 2016ClinicalTrials.gov NCT02991118 · fetched Nov 12, 2026
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin IntolerantPHASE3 · COMPLETED · started Nov 16, 2016ClinicalTrials.gov NCT02988115 · fetched Nov 12, 2026
- Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)PHASE3 · COMPLETED · started Jan 21, 2016ClinicalTrials.gov NCT02666664 · fetched Nov 12, 2026
- A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mgPHASE2 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02659397 · fetched Nov 12, 2026
- Evaluation of ETC-1002 in Participants With Hypercholesterolemia and HypertensionPHASE2 · COMPLETED · started Jun 16, 2014ClinicalTrials.gov NCT02178098 · fetched Nov 12, 2026
- Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin TherapyPHASE2 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02072161 · fetched Nov 12, 2026
- Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsPHASE2 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01941836 · fetched Nov 12, 2026
- A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaPHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01779453 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin IntolerancePHASE2 · COMPLETED · started Oct 4, 2012ClinicalTrials.gov NCT01751984 · fetched Nov 12, 2026
- A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesPHASE2 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01607294 · fetched Nov 12, 2026
- A Multiple Ascending Dose Study of ETC-1002 in Healthy SubjectsPHASE1 · COMPLETED · started Oct 25, 2011ClinicalTrials.gov NCT01485146 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated TriglyceridesPHASE2 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01262638 · fetched Nov 12, 2026
- A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild DyslipidemiaPHASE1 · COMPLETED · started Apr 20, 2010ClinicalTrials.gov NCT01105598 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 8, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 2, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 3, 2026 · fetched Nov 12, 2026